"There is a great sense of community and interconnectedness among the folks who are here," said an attendee of the 10th Annual Friedreich's Ataxia Symposium.
News abounds this first week of spring, and we bring you fresh insights from new scientific studies cultivated by experts at The Children’s Hospital of Philadelphia. But first, take a moment to celebrate a special award that recognizes the dedication of pediatric oncologist Richard Aplenc, MD, PhD, MSCE.
Children with Down syndrome (also known as Trisomy 21) are prone to obesity. Their families may be concerned about their future risks for cardiovascular problems as well as their quality of life.
Researchers from the Sleep Center at The Children’s Hospital of Philadelphia are set to launch the “Steroids for Pediatric Research in Kids (SPARK)” trial in September that will investigate the use of nasal corticosteroids as a possible treatment for OSAS.
The overall goal of the Pei Lab is to understand how different organs react to energy cues and communicate with each other to maintain whole-organism homeostasis in both physiological and pathological contexts.
